Multicenter prospective validation of PanClaudinAI: An AI for predicting Claudin 18.2 from CT in pancreatic cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers ...

Gustave Roussy partners with One Biosciences, a techbio company that harnesses single cell technology and AI to develop advanced precision diagnostics. The collaboration aims to further demonstrate ...

Genomic and transcriptomic correlates of deep PSA response in patients with mHSPC. Despite major advances in combination treatment strategies for metastatic hormone-sensitive prostate cancer (mHSPC), ...

Presentations highlight the clinical utility of AI-powered models and multimodal profiling for biomarker discovery, treatment response prediction, and patient stratification across diverse solid ...